MedPath
HSA Approval

LINCOMYCIN INJECTION 300 mg/ml

SIN06683P

LINCOMYCIN INJECTION 300 mg/ml

LINCOMYCIN INJECTION 300 mg/ml

November 20, 1991

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01FF02

lincomycin

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL IND CO LTD

Active Ingredients

LINCOMYCIN HCl EQV LINCOMYCIN

300 mg/ml

Lincomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LINCOMYCIN INJECTION 300 mg/ml - HSA Approval | MedPath